Placebo to match carbetocin 11.4 mg/ml (2ml /vial) clinical trials

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

This study is testing a nasal spray called Carbetocin to see if it can help adults with Prader-Willi Syndrome manage their constant hunger, known as hyperphagia. We want to find out if it makes a noticeable difference compared to a dummy spray over 12 weeks.